Related Experiment Video
Updated: Jun 22, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Alpha-1-Antitrypsin Deficiency in Children-Unmet Needs Concerning the Liver Manifestation
Joelle Lemke1, Alexander Weigert1, Soyhan Bagci1,2
1Department of Pediatric Gastroenterology and Hepatology, University Hospital of Bonn Children's Hospital, 53127 Bonn, Germany.
Insights
Neonatal icterus prolongatus in infants with alpha-1-antitrypsin deficiency (AATD) is a significant predictor of severe liver disease. Early identification of this symptom can help anticipate poor outcomes in children with AATD.
Area of Science:
- Pediatric Hepatology
- Genetic Liver Diseases
- Clinical Genetics
Background:
- Alpha-1-antitrypsin deficiency (AATD) is an inherited disorder that can lead to severe liver and lung disease.
- Identifying predictors of poor outcomes in pediatric AATD is crucial for timely intervention.
Purpose of the Study:
- To analyze the clinical course of 45 children with severe alpha-1-antitrypsin deficiency (AATD).
- To identify potential predictors of poor outcomes in pediatric AATD.
Main Methods:
- Retrospective and prospective analysis of clinical and biological data from 45 children with homozygous or compound heterozygous AATD.
- Data collection included questionnaires, laboratory values, sonography, and biopsy findings.
- Liver disease severity was classified into four grades.
Main Results:
- Most patients (86.7%) had Pi*ZZ genotype; one had a novel compound heterozygous genotype.
- 66.7% had mild/no liver disease, 20% moderate, and 13.3% severe.
- Neonatal icterus prolongatus was significantly associated with severe liver disease (p=0.012).
Conclusions:
- Neonatal icterus prolongatus is a key early indicator of severe liver disease in pediatric AATD.
- Further research is needed to explore the link between atopic comorbidity and AATD.
Objectives:
This study aimed to analyse the clinical course of 45 children with severe alpha-1-antitrypsin deficiency (AATD) registered in our clinic to detect possible predictors of poor outcomes.
Methods:
The clinical and biological data of 45 patients with homozygous or compound heterozygous AATD were analysed. The data were collected retrospectively going back to 2005 and prospectively from May 2020 until October 2021. It was based on questionnaires, laboratory values, sonography, and biopsy findings. Liver disease was classified into four grades depending on the grade of liver disease: mild or no liver disease, moderate disease, severe disease, and liver transplantation.
Results:
Thirty-nine patients (86.7%) had a Pi*ZZ and five (11.1%) a Pi*SZ genotype. One patient showed a new, not-yet-described compound heterozygous genotype (Pi*Z + Asp95Asn). A total of 66.7% of the cohort showed mild or no liver disease, 20% moderate, and 13.3% severe. AATD was diagnosed in most cases because of liver abnormalities, such as the elevation of transaminases (42.2%). A total of 29.4% of the patients with neonatal icterus prolongatus developed severe liver disease, and 25.7% were born small for their gestational age (SGA). Diseases of the atopic type were reported in 47.4% of the cases.
Conclusions:
The presence of neonatal icterus prolongatus in the first weeks of life was significantly more likely in severe courses of liver disease (r = 0.371, p = 0.012). A tendency toward atopic comorbidity in AAT-deficient children needs to be further evaluated.
Related Concept Videos
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Lysosomal Hydrolases
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Pancreatitis II: Collaborative Care
Assessment:

